Cargando…
Dominant Role of the Gut Microbiota in Chemotherapy Induced Neuropathic Pain
Chemotherapy induced peripheral neuropathy (CIPN), a toxic side effect of some cancer treatments, negatively impacts patient outcomes and drastically reduces survivor’s quality of life (QOL). Uncovering the mechanisms driving chemotherapy-induced CIPN is urgently needed to facilitate the development...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937259/ https://www.ncbi.nlm.nih.gov/pubmed/31889131 http://dx.doi.org/10.1038/s41598-019-56832-x |
_version_ | 1783483843934683136 |
---|---|
author | Ramakrishna, Chandran Corleto, Jose Ruegger, Paul M. Logan, Geoffrey D. Peacock, Beth B. Mendonca, Stacee Yamaki, Shanni Adamson, Trinka Ermel, Richard McKemy, David Borneman, James Cantin, Edouard M. |
author_facet | Ramakrishna, Chandran Corleto, Jose Ruegger, Paul M. Logan, Geoffrey D. Peacock, Beth B. Mendonca, Stacee Yamaki, Shanni Adamson, Trinka Ermel, Richard McKemy, David Borneman, James Cantin, Edouard M. |
author_sort | Ramakrishna, Chandran |
collection | PubMed |
description | Chemotherapy induced peripheral neuropathy (CIPN), a toxic side effect of some cancer treatments, negatively impacts patient outcomes and drastically reduces survivor’s quality of life (QOL). Uncovering the mechanisms driving chemotherapy-induced CIPN is urgently needed to facilitate the development of effective treatments, as currently there are none. Observing that C57BL/6 (B6) and 129SvEv (129) mice are respectively sensitive and resistant to Paclitaxel-induced pain, we investigated the involvement of the gut microbiota in this extreme phenotypic response. Reciprocal gut microbiota transfers between B6 and 129 mice as well as antibiotic depletion causally linked gut microbes to Paclitaxel-induced pain sensitivity and resistance. Microglia proliferated in the spinal cords of Paclitaxel treated mice harboring the pain-sensitive B6 microbiota but not the pain-resistant 129 microbiota, which exhibited a notable absence of infiltrating immune cells. Paclitaxel decreased the abundance of Akkermansia muciniphila, which could compromise barrier integrity resulting in systemic exposure to bacterial metabolites and products – that acting via the gut-immune-brain axis – could result in altered brain function. Other bacterial taxa that consistently associated with both bacteria and pain as well as microglia and pain were identified, lending support to our hypothesis that microglia are causally involved in CIPN, and that gut bacteria are drivers of this phenotype. |
format | Online Article Text |
id | pubmed-6937259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-69372592020-01-06 Dominant Role of the Gut Microbiota in Chemotherapy Induced Neuropathic Pain Ramakrishna, Chandran Corleto, Jose Ruegger, Paul M. Logan, Geoffrey D. Peacock, Beth B. Mendonca, Stacee Yamaki, Shanni Adamson, Trinka Ermel, Richard McKemy, David Borneman, James Cantin, Edouard M. Sci Rep Article Chemotherapy induced peripheral neuropathy (CIPN), a toxic side effect of some cancer treatments, negatively impacts patient outcomes and drastically reduces survivor’s quality of life (QOL). Uncovering the mechanisms driving chemotherapy-induced CIPN is urgently needed to facilitate the development of effective treatments, as currently there are none. Observing that C57BL/6 (B6) and 129SvEv (129) mice are respectively sensitive and resistant to Paclitaxel-induced pain, we investigated the involvement of the gut microbiota in this extreme phenotypic response. Reciprocal gut microbiota transfers between B6 and 129 mice as well as antibiotic depletion causally linked gut microbes to Paclitaxel-induced pain sensitivity and resistance. Microglia proliferated in the spinal cords of Paclitaxel treated mice harboring the pain-sensitive B6 microbiota but not the pain-resistant 129 microbiota, which exhibited a notable absence of infiltrating immune cells. Paclitaxel decreased the abundance of Akkermansia muciniphila, which could compromise barrier integrity resulting in systemic exposure to bacterial metabolites and products – that acting via the gut-immune-brain axis – could result in altered brain function. Other bacterial taxa that consistently associated with both bacteria and pain as well as microglia and pain were identified, lending support to our hypothesis that microglia are causally involved in CIPN, and that gut bacteria are drivers of this phenotype. Nature Publishing Group UK 2019-12-30 /pmc/articles/PMC6937259/ /pubmed/31889131 http://dx.doi.org/10.1038/s41598-019-56832-x Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Ramakrishna, Chandran Corleto, Jose Ruegger, Paul M. Logan, Geoffrey D. Peacock, Beth B. Mendonca, Stacee Yamaki, Shanni Adamson, Trinka Ermel, Richard McKemy, David Borneman, James Cantin, Edouard M. Dominant Role of the Gut Microbiota in Chemotherapy Induced Neuropathic Pain |
title | Dominant Role of the Gut Microbiota in Chemotherapy Induced Neuropathic Pain |
title_full | Dominant Role of the Gut Microbiota in Chemotherapy Induced Neuropathic Pain |
title_fullStr | Dominant Role of the Gut Microbiota in Chemotherapy Induced Neuropathic Pain |
title_full_unstemmed | Dominant Role of the Gut Microbiota in Chemotherapy Induced Neuropathic Pain |
title_short | Dominant Role of the Gut Microbiota in Chemotherapy Induced Neuropathic Pain |
title_sort | dominant role of the gut microbiota in chemotherapy induced neuropathic pain |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937259/ https://www.ncbi.nlm.nih.gov/pubmed/31889131 http://dx.doi.org/10.1038/s41598-019-56832-x |
work_keys_str_mv | AT ramakrishnachandran dominantroleofthegutmicrobiotainchemotherapyinducedneuropathicpain AT corletojose dominantroleofthegutmicrobiotainchemotherapyinducedneuropathicpain AT rueggerpaulm dominantroleofthegutmicrobiotainchemotherapyinducedneuropathicpain AT logangeoffreyd dominantroleofthegutmicrobiotainchemotherapyinducedneuropathicpain AT peacockbethb dominantroleofthegutmicrobiotainchemotherapyinducedneuropathicpain AT mendoncastacee dominantroleofthegutmicrobiotainchemotherapyinducedneuropathicpain AT yamakishanni dominantroleofthegutmicrobiotainchemotherapyinducedneuropathicpain AT adamsontrinka dominantroleofthegutmicrobiotainchemotherapyinducedneuropathicpain AT ermelrichard dominantroleofthegutmicrobiotainchemotherapyinducedneuropathicpain AT mckemydavid dominantroleofthegutmicrobiotainchemotherapyinducedneuropathicpain AT bornemanjames dominantroleofthegutmicrobiotainchemotherapyinducedneuropathicpain AT cantinedouardm dominantroleofthegutmicrobiotainchemotherapyinducedneuropathicpain |